Literature DB >> 24956246

Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia.

Marco Spangaro1, Marta Bosia, Andrea Zanoletti, Margherita Bechi, Buonocore Mariachiara, Adele Pirovano, Cristina Lorenzi, Placido Bramanti, Enrico Smeraldi, Roberto Cavallaro.   

Abstract

AIM: To evaluate the effect of functional polymorphisms (rs4354668 and rs2731880) of the excitatory amino acid transporters (EAAT1 and 2) on the cognitive dysfunction that characterizes schizophrenia. MATERIALS &
METHODS: One hundred and ninety two subjects diagnosed with schizophrenia were assessed with Brief Assessment of Cognition in Schizophrenia, Wisconsin Card Sorting Test, Continuous Performance Test and N-back test and genotyped for rs4354668 and rs2731880.
RESULTS: ANOVA showed a significant difference among both EAAT1 and EAAT2 genotype groups on different cognitive measures. Worse performances were observed among carriers of the genotypes associated with lower EAAT expression.
CONCLUSION: RESULTS suggest that impaired activity and EAAT expression could influence cognitive performances in schizophrenia, thus representing a target of interest for development of pharmacological strategies aimed to improve cognition.

Entities:  

Keywords:  EAAT1; EAAT2; cognitive impairment; glutamate uptake; schizophrenia

Mesh:

Substances:

Year:  2014        PMID: 24956246     DOI: 10.2217/pgs.14.42

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  12 in total

1.  Glutamate Transporters: Expression and Function in Oligodendrocytes.

Authors:  Edna Suárez-Pozos; Elizabeth J Thomason; Babette Fuss
Journal:  Neurochem Res       Date:  2019-01-09       Impact factor: 3.996

Review 2.  The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.

Authors:  Edward Pajarillo; Asha Rizor; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  Neuropharmacology       Date:  2019-03-06       Impact factor: 5.250

Review 3.  The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders.

Authors:  Sahar Alijanpour; Mohammad Miryounesi; Soudeh Ghafouri-Fard
Journal:  Metab Brain Dis       Date:  2022-09-29       Impact factor: 3.655

4.  A Glutamate Transporter EAAT1 Gene Variant Influences Amygdala Functional Connectivity in Bipolar Disorder.

Authors:  Sara Poletti; Martina Riberto; Benedetta Vai; Davide Ghiglino; Cristina Lorenzi; Alice Vitali; Silvia Brioschi; Clara Locatelli; Alessandro Serretti; Cristina Colombo; Francesco Benedetti
Journal:  J Mol Neurosci       Date:  2018-08-02       Impact factor: 3.444

5.  Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia.

Authors:  S M O'Donovan; K Hasselfeld; D Bauer; M Simmons; P Roussos; V Haroutunian; J H Meador-Woodruff; R E McCullumsmith
Journal:  Transl Psychiatry       Date:  2015-06-09       Impact factor: 6.222

Review 6.  Brain NMDA Receptors in Schizophrenia and Depression.

Authors:  Albert Adell
Journal:  Biomolecules       Date:  2020-06-23

Review 7.  Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders.

Authors:  Georgia M Parkin; Madhara Udawela; Andrew Gibbons; Brian Dean
Journal:  World J Psychiatry       Date:  2018-06-28

8.  Polymorphism of rs12294045 in EAAT2 gene is potentially associated with schizophrenia in Chinese Han population.

Authors:  Lina Wang; Tantan Ma; Dongdong Qiao; Kaiyan Cui; Xiaojiao Bi; Chao Han; Limin Yang; Mengmeng Sun; Lanfen Liu
Journal:  BMC Psychiatry       Date:  2022-03-08       Impact factor: 3.630

Review 9.  Beyond NMDA Receptors: Homeostasis at the Glutamate Tripartite Synapse and Its Contributions to Cognitive Dysfunction in Schizophrenia.

Authors:  Hagar Bauminger; Inna Gaisler-Salomon
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

Review 10.  Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.

Authors:  João M N Duarte; Lijing Xin
Journal:  Neurochem Res       Date:  2018-04-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.